Renhe

No reliable, uniquely identifying source has been supplied for the Renhe subject. The Chinese name 仁和 is not sufficient on its own to determine whether the intended subject is a standalone consumer brand, a pharmaceutical company, a product trademark, or another organization using the same name. Consequently, no founding event, ownership transition, product launch, market expansion, leadership appointment, or other historical milestone is attributed here. A verified Wikipedia title, Wikidata identifier, official corporate website, trademark registration, or other authoritative reference would be needed to distinguish the intended subject from similarly named entities and to support a complete historical account.

Product categories. Over-the-counter drugs

• 2022

  Renhe Pharmacy's Fuyanjie Apologizes for Inappropriate Advertising and Removes Related Products

  The product page of Fuyanjie's official flagship store drew controversy for disrespecting women. The brand issued an apology letter, saying it had set up a special team, removed the relevant products and was cooperating with an investigation. Yicai noted that the brand's manufacturer, Jiangxi Kangmei, belongs to Renhe Pharmacy. Progress: the brand has publicly apologized and announced rectification. Entities: Fuyanjie, Jiangxi Kangmei Pharmaceutical Health Products Co., Ltd. Scope: the Fuyanjie brand under Jiangxi Kangmei Pharmaceutical Health Products Co., Ltd.

  Source

• 2021

  Report raises concerns about Renhe Pharmaceutical’s control of branded OEM products

  A report described numerous products sold under the Renhe name and alleged that insufficient control over branded OEM products had cast a shadow over Renhe Pharmaceutical’s brand. The report said it had sought confirmation from the company but had not received a response by publication.

  Source

• 2020

  OEM products falsely advertised; subsidiary fined for selling substandard drugs

  Renhe-related 'HP toothpaste' used a 'cosmetics registration number' to advertise against Helicobacter pylori, and white-label anti-hair-loss shampoo used another company's approval number while claiming it was 'developed by Renhe Pharmaceutical', prompting criticism of false advertising and the chaotic practice of 'one approval number for multiple products'; a subsidiary was previously fined for selling substandard drugs and using absolute claims in advertising; the company involved in a vulgar ad for its Fuyanjie brand was fined 1.3 million yuan. The brand has been criticized for 'emphasizing marketing over R&D'.

  Source

Read more

• 2021.07.06

  Reported2021.07.08

  Renhe Pharmaceutical announces planned acquisition of stakes in seven companies[6]仁和药业宣布拟收购七家公司股权finance.sina.com.cn

  Renhe Pharmaceutical announced a planned acquisition of 80% stakes in seven companies for RMB 719 million. The proposed targets include Shenzhen Sanpu Natural Cosmetics Co., Ltd. and six other companies.

• 2021.05.25

  Reported2021.05.25

  Report raises concerns about Renhe Pharmaceutical’s control of branded OEM products[5]Report raises concerns about Renhe Pharmaceutical’s control of branded OEM productsfinance.sina.com.cn

  A report described numerous products sold under the Renhe name and alleged that insufficient control over branded OEM products had cast a shadow over Renhe Pharmaceutical’s brand. The report said it had sought confirmation from the company but had not received a response by publication.

Read more

1. 1Renhe Pharmacy's Fuyanjie Apologizes for Inappropriate Advertising and Removes Related Productsyicai.com
2. 2OEM products falsely advertised; subsidiary fined for selling substandard drugsfinance.ifeng.com
3. 3OEM products falsely advertised; subsidiary fined for selling substandard drugsnews.qq.com
4. 4OEM products falsely advertised; subsidiary fined for selling substandard drugsfinance.sina.com.cn
5. 5Report raises concerns about Renhe Pharmaceutical’s control of branded OEM productsfinance.sina.com.cn
6. 6仁和药业宣布拟收购七家公司股权finance.sina.com.cn